We are live on ! Find out more
BCM

Boxer Capital Management Portfolio holdings

AUM $762M
1-Year Est. Return 1,125.36%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+1,125.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
–
Cap. Flow
+$1.34B
Cap. Flow %
114.29%
Top 10 Hldgs %
60.16%
Holding
60
New
60
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$216M
2
SWTX
SpringWorks Therapeutics
SWTX
+$120M
3
NUVL
Nuvalent
NUVL
+$105M
4
MRUS
Merus
MRUS
+$91.2M
5
RNAM
Avidity Biosciences
RNAM
+$72.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZNTL icon
51
Zentalis Pharmaceuticals
ZNTL
$347M
$1.36M 0.12%
+450,000
New +$1.47M
BDTX icon
52
Black Diamond Therapeutics
BDTX
$102M
$1.08M 0.09%
+506,000
New +$1.45M
OBIO icon
53
Orchestra BioMed
OBIO
$251M
$953K 0.08%
+238,193
New +$1.28M
ZURA icon
54
Zura Bio
ZURA
$541M
$750K 0.06%
+300,000
New +$1.07M
MIST icon
55
Milestone Pharmaceuticals
MIST
$147M
$729K 0.06%
+309,007
New +$530K
BOLD
56
Boundless Bio
BOLD
$60M
$725K 0.06%
+250,000
New +$728K
BCAB icon
57
BioAtla
BCAB
$5.61M
$406K 0.03%
+13,727
New +$1.15M
DBVT
58
DBV Technologies
DBVT
$811M
$155K 0.01%
+50,000
New +$170K
NUVB.WS
59
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$61.3K 0.01%
+266,666
New +$34.5K
SRZNW icon
60
Surrozen Inc Warrant
SRZNW
$1.66K ﹤0.01%
+66,666
New +$1.25K
1 2
3

Similar funds

GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
PMWMG
Parr McKnight Wealth Management Group Minneapolis, Minnesota $763M AUM 13.49% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CCIP
Camrose Capital Investment Partners London, United Kingdom $764M AUM 0.9% 1-Year Est. Return
FA
Fiducient Advisors Chicago, Illinois $765M AUM 12.73% 1-Year Est. Return

Boxer Capital Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Boxer Capital Management, which disclosed 60 positions worth $1.17B. Its ten largest holdings account for 60% of the portfolio.

Its largest position is Revolution Medicines: 4,279,464 shares worth $187M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Boxer Capital Management's largest Q4 2024 buy was Revolution Medicines: 4,279,464 shares worth $187M.
  • Boxer Capital Management's ten largest holdings make up 60% of its $1.17B portfolio in Q4 2024.
  • Boxer Capital Management disclosed 60 positions in Q4 2024, its first 13F filing on record.

Based on Boxer Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.